Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Critical Illness × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vitamin D Deficiency 1 Stroke 1 Spinal Cord Injuries 1 Seizures 1 Polyps 1 Neoplasms 1 Meningitis 1 Intracranial Hemorrhages 1 Intracranial Aneurysm 1 Critical Illness 1 Craniocerebral Trauma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenomatous Polyps 1 Adenoma 1

Interventions

Spironolactone 1 Darbepoetin alfa 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02881957 2022-06-15

Hypovitaminosis D in Neurocritical Patients

University of Utah

Phase 2/3 Completed

274 enrolled 16 charts

Brain Neoplasms, Intracranial Aneurysm, Craniocerebral Trauma, Meningitis, Seizures, Spinal Cord Injuries, Vitamin D Deficiency, Critical Illness, Intracranial Hemorrhages, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡